Human cancer cells selected for resistance to multiple hydrophobic cytotoxic drugs express
the cell surface P-glycoprotein, which is the product of the MDRl gene. In this review Michael …

… concentrations of chemotherapeutic agents, a … tumor cell-based and DC-based vaccines.
Our results also suggest a new mechanism of how a very low dose of chemotherapeutic agents …

… of several cancer cell lines treated with different anticancer drugs using a set of common
senescence markers. Our results point to a cell type and drug diversity in the cancer cell …

… to the normal cells. In this paper, two models for cancer chemotherapy are considered and
the … The first model considers the case when the chemotherapeutic agents kill cancer cells …

… Though chemotherapeutic agents have effect on cancer cells, their usage … chemotherapeutic
agents in less dosage with higher dosage of polyphenols are less cytotoxic to normal cells. …

… of the main reasons for chemotherapy failure, leading to the … chemotherapeutic drug out
of cancer cells, decrease intracellular accumulation of anticancer drug and result in cancer cell …

… of administering chemotherapy on the basis of metabolic differences between normal and
cancer cells. Perhaps this approach will finally lead to effective chemotherapy for many types …

… for cancers. We therefore studied whether combinations of the HRI lovastatin with standard
chemotherapeutic agents would augment apoptosis in colon cancer cells. In the colon …

… is the preferred choice in case of metastatic cancers [2]. Chemotherapy leads to the suppression
of cell division which is a characteristic feature of cancer cells. However, rapidly dividing …

… of PUMA by chemotherapeutic agents is abolished in p53-deficient lung cancer cells.
PUMA expression resulted in potent growth suppression of lung cancer cells and suppressed …